These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26917087)

  • 1. Synergistic Effect of Cold Atmospheric Plasma and Drug Loaded Core-shell Nanoparticles on Inhibiting Breast Cancer Cell Growth.
    Zhu W; Lee SJ; Castro NJ; Yan D; Keidar M; Zhang LG
    Sci Rep; 2016 Feb; 6():21974. PubMed ID: 26917087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel-Loaded Core-Shell Magnetic Nanoparticles and Cold Atmospheric Plasma Inhibit Non-Small Cell Lung Cancer Growth.
    Yu H; Wang Y; Wang S; Li X; Li W; Ding D; Gong X; Keidar M; Zhang W
    ACS Appl Mater Interfaces; 2018 Dec; 10(50):43462-43471. PubMed ID: 30375840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cold atmospheric plasma and iron oxide-based magnetic nanoparticles for synergetic lung cancer therapy.
    Li W; Yu H; Ding D; Chen Z; Wang Y; Wang S; Li X; Keidar M; Zhang W
    Free Radic Biol Med; 2019 Jan; 130():71-81. PubMed ID: 30342190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
    Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L
    Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.
    Wang H; Zhao Y; Wang H; Gong J; He H; Shin MC; Yang VC; Huang Y
    J Control Release; 2014 Oct; 192():47-56. PubMed ID: 25003794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer.
    Thamake SI; Raut SL; Gryczynski Z; Ranjan AP; Vishwanatha JK
    Biomaterials; 2012 Oct; 33(29):7164-73. PubMed ID: 22795543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
    Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
    J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rationally designed photo-chemo core-shell nanomedicine for inhibiting the migration of metastatic breast cancer cells followed by photodynamic killing.
    Malarvizhi GL; Chandran P; Retnakumari AP; Ramachandran R; Gupta N; Nair S; Koyakutty M
    Nanomedicine; 2014 Apr; 10(3):579-87. PubMed ID: 24200524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polymer-protein core-shell nanomedicine for inhibiting cancer migration followed by photo-triggered killing.
    Ramachandran R; Malarvizhi GL; Chandran P; Gupta N; Menon D; Panikar D; Nair S; Koyakutty M
    J Biomed Nanotechnol; 2014 Aug; 10(8):1401-15. PubMed ID: 25016641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles.
    Min KH; Lee HJ; Kim K; Kwon IC; Jeong SY; Lee SC
    Biomaterials; 2012 Aug; 33(23):5788-97. PubMed ID: 22591612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable self-assembled nanoparticles of poly (D,L-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer.
    Huang J; Zhang H; Yu Y; Chen Y; Wang D; Zhang G; Zhou G; Liu J; Sun Z; Sun D; Lu Y; Zhong Y
    Biomaterials; 2014 Jan; 35(1):550-66. PubMed ID: 24135268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
    Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
    Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticles.
    Feng Q; Yu MZ; Wang JC; Hou WJ; Gao LY; Ma XF; Pei XW; Niu YJ; Liu XY; Qiu C; Pang WH; Du LL; Zhang Q
    Biomaterials; 2014 Jun; 35(18):5028-38. PubMed ID: 24680191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(D, L-lactide-co-glycolide)/montmorillonite nanoparticles for improved oral delivery of exemestane.
    Li Z; Liu K; Sun P; Mei L; Hao T; Tian Y; Tang Z; Li L; Chen D
    J Microencapsul; 2013; 30(5):432-40. PubMed ID: 23517067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosensitization of TPGS-emulsified docetaxel-loaded poly(lactic-co-glycolic acid) nanoparticles in CNE-1 and A549 cells.
    Shi W; Yuan Y; Chu M; Zhao S; Song Q; Mu X; Xu S; Zhang Z; Yang K
    J Biomater Appl; 2016 Mar; 30(8):1127-41. PubMed ID: 26608458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel nanosystem to enhance the antitumor activity of lapatinib in breast cancer treatment: Therapeutic efficacy evaluation.
    Huo ZJ; Wang SJ; Wang ZQ; Zuo WS; Liu P; Pang B; Liu K
    Cancer Sci; 2015 Oct; 106(10):1429-37. PubMed ID: 26177628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.